These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8178556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
    Galindo CM, Acosta CJ, Schellenberg D, Aponte JJ, Roca A, Oettli A, Urassa H, Armstrong Schellenberg J, Kahigwa E, Ascaso C, Mshinda H, Lwilla F, Vidal J, Menendez C, Tanner M, Alonso PL.
    Parasite Immunol; 2000 Sep; 22(9):437-43. PubMed ID: 10972850
    [Abstract] [Full Text] [Related]

  • 4. SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission.
    Teuscher T, Schellenberg JR, Bastos de Azevedo I, Hurt N, Smith T, Hayes R, Masanja H, Silva Y, Lopez MC, Kitua A.
    Vaccine; 1994 Mar; 12(4):328-36. PubMed ID: 8178555
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.
    Valero MV, Amador LR, Galindo C, Figueroa J, Bello MS, Murillo LA, Mora AL, Patarroyo G, Rocha CL, Rojas M.
    Lancet; 1993 Mar 20; 341(8847):705-10. PubMed ID: 8095622
    [Abstract] [Full Text] [Related]

  • 8. Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.
    Kashala O, Amador R, Valero MV, Moreno A, Barbosa A, Nickel B, Daubenberger CA, Guzman F, Pluschke G, Patarroyo ME.
    Vaccine; 2002 May 22; 20(17-18):2263-77. PubMed ID: 12009282
    [Abstract] [Full Text] [Related]

  • 9. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2003 May 22; (1):CD000129. PubMed ID: 12535387
    [Abstract] [Full Text] [Related]

  • 10. Humoral immune response to the anti-malaria vaccine SPf66 in the Colombian Atrato River region.
    Lopera TM, Restrepo M, Blair S, García HI.
    Mem Inst Oswaldo Cruz; 1998 May 22; 93(4):495-500. PubMed ID: 9711340
    [Abstract] [Full Text] [Related]

  • 11. A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design.
    Alonso PL, Tanner M, Smith T, Hayes RJ, Schellenberg JA, Lopez MC, Bastos de Azevedo I, Menendez C, Lyimo E, Weiss N.
    Vaccine; 1994 Feb 22; 12(2):181-6. PubMed ID: 8147101
    [Abstract] [Full Text] [Related]

  • 12. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
    Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Wah E, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff JC, Heppner DG.
    Lancet; 1996 Sep 14; 348(9029):701-7. PubMed ID: 8806288
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
    Urdaneta M, Prata A, Struchiner CJ, Tosta CE, Tauil P, Boulos M.
    Am J Trop Med Hyg; 1998 Mar 14; 58(3):378-85. PubMed ID: 9546423
    [Abstract] [Full Text] [Related]

  • 14. WITHDRAWN: Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2007 Jul 18; 2003(4):CD000129. PubMed ID: 17636596
    [Abstract] [Full Text] [Related]

  • 15. Serological responses of Gambian children to immunization with the malaria vaccine SPf66.
    Metzger WG, Haywood M, D'Alessandro U, Drakeley CJ, Weiss H, Bojang K, Targett GA, Greenwood BM.
    Parasite Immunol; 1999 Jul 18; 21(7):335-40. PubMed ID: 10417667
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.
    Valero MV, Amador R, Aponte JJ, Narvaez A, Galindo C, Silva Y, Rosas J, Guzman F, Patarroyo ME.
    Vaccine; 1996 Oct 18; 14(15):1466-70. PubMed ID: 8994323
    [Abstract] [Full Text] [Related]

  • 17. SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand.
    Migasena S, Heppner DG, Kyle DE, Chongsuphajaisiddhi T, Gordon DM, Suntharasamai P, Permpanich B, Brockman A, Pitiuttutham P, Wongsrichanalai C, Srisuriya P, Phonrat B, Pavanand K, Viravan C, Ballou WR.
    Acta Trop; 1997 Sep 30; 67(3):215-27. PubMed ID: 9241386
    [Abstract] [Full Text] [Related]

  • 18. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
    Bermúdez A, Reyes C, Guzmán F, Vanegas M, Rosas J, Amador R, Rodríguez R, Patarroyo MA, Patarroyo ME.
    Vaccine; 2007 May 30; 25(22):4487-501. PubMed ID: 17403557
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.
    Amador R, Moreno A, Murillo LA, Sierra O, Saavedra D, Rojas M, Mora AL, Rocha CL, Alvarado F, Falla JC.
    J Infect Dis; 1992 Jul 30; 166(1):139-44. PubMed ID: 1607685
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.